ELEV Shares Outstanding History Table | ||||||||||||||||||||||||
Also see: ELEV Market Cap History ELEV YTD Return |
ELEV Shares Outstanding History Table | ||||||||||||||||||||||||
Also see: ELEV Market Cap History ELEV YTD Return |
ELEV Shares Outstanding History Chart | |||||||||||||||||||||||||
+32.57% CAGR Mouse over chart for data details
|
ELEV Stock Price Chart |
About Elevation Oncology Inc |
Elevation Oncology is a precision oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Co.'s primary drug development candidate, seribantumab, is an Anti-HER3 monoclonal antibody and potential targeted therapy for solid tumors driven by neuregulin-1, a type of genomic alteration and oncogenic driver, and other receptor tyrosine-protein kinase erbB- (HER3), genomically defined cancers. Co. is also evaluating opportunities for pipeline expansion including prioritizing additional targeted therapy approaches in tumor types defined by genomic driver alterations. We show 11 historical shares outstanding datapoints in our coverage of ELEV's shares outstanding history. Understanding the changing numbers of ELEV shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ELEV versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ELEV by allowing them to research ELEV shares outstanding history as well as any other stock in our coverage universe. |
ELEV Current Stock Quote |
Free ELEV Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: Shares Outstanding Importance | |
|
ELEV Share Performance |
Shares Outstanding Peers |
Elevation Oncology (ELEV) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ELGX Shares Outstanding History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.